COVID-19 Linked to Clogged Arteries and Increased Heart Attack and Stroke Risk

COVID-19 Linked to Clogged Arteries and Increased Heart Attack and Stroke Risk

A new study has found that COVID-19 may accelerate plaque buildup in the arteries (atherosclerosis) and raise the risk of heart attack and stroke.

“This study builds on prior research linking COVID-19 to systemic inflammation and long-term cardiovascular complications,” says study senior author Junbo Ge, MD, a professor and the director of the cardiology department at Zhongshan Hospital at Fudan University in Shanghai, China.

“COVID-19 is not just a respiratory illness: It has lasting cardiovascular consequences,” Dr. Ge says. “Even mild infections may accelerate atherosclerosis and increase heart attack risk.”

COVID-19 Poses Long-Term Health Risks

Now that we’ve been living with COVID-19 for the past five years, many Americans may not view the virus as a serious health threat. A poll from Gallup last year found that only 20 percent of U.S. adults were very or somewhat worried that they would contract COVID-19.

Concerns may have faded as these infections are generally milder than earlier in the pandemic, and hospitalization rates have declined over the past couple years.

Still, health threats from COVID-19 can linger. While typical respiratory symptoms may pass rather quickly, other health effects can spring up later, including problems with the gut, kidneys, brain, nervous system, and heart.

How COVID-19 Affects the Arteries

To see how the coronavirus that causes COVID-19, SARS-CoV-2, might affect coronary arteries that supply blood to the heart, Ge and his collaborators reviewed scans of the heart and blood vessels in about 800 older adults, taken between September 2018 and October 2023.

Participants, who were 64 years old on average, had at least two examinations performed about three years apart. A total of 690 adults with an associated 2,108 coronary plaques had confirmed COVID-19 over this time period, and 113 adults with 480 coronary plaques did not.

Ge and his team compared how plaque volumes changed between initial scans and follow-up imaging. The findings showed that plaque volumes grew faster in participants who had COVID-19.

In participants with COVID-19, the incidence of lesions (abnormal growths in blood vessels) developing into high-risk plaques that are likely to break away and cause a clot was just over 20 percent, compared with almost 16 percent in participants who didn’t have COVID-19.

“Inflammation following COVID-19 can lead to ongoing plaque growth, particularly in high-risk, noncalcified plaques,” says Ge.

The investigative team also found a 27 percent incident rate for coronary inflammation in the COVID group, versus just under 20 percent in the non-COVID group.

In addition, participants who’d had COVID-19 experienced a greater chance of having target lesion failure, in which a lesion in a blood vessel targeted with treatment is unsuccessful.

 The rate was 10.4 percent in the COVID group, versus 3.1 percent in the non-COVID group. This indicates increased heart attack and stroke risk, the authors wrote.

“While systemic inflammation was expected to influence atherosclerosis, the magnitude of plaque progression underscores the profound impact of COVID-19,” says Ge. “The study shows that even nonhospitalized COVID-19 patients face heightened risks of plaque progression and cardiovascular events.”

Taking Action to Protect the Heart

Patricia Nguyen, MD, an associate professor of cardiovascular medicine at Stanford Health Care in California, notes that these new findings align with her own previous research, which found a link between respiratory viruses, inflammation, and a higher risk of heart disease complications.

“The results are intriguing and correspond in some ways to research we’ve done looking at plaque on a cellular level to see why patients who have viral infections like flu and SARS have an increased risk of heart attack,” says Dr. Nguyen.

She stresses, however, that this study is limited because it’s retrospective — looking at already existing imaging and data, rather than directly following a group of participants. Furthermore, patients were all Asian and selected from a single health center, reducing any generalization of results to other populations.

Also, the analysis did not take lifestyle factors into account.

“There is no information about diet and exercise, for example,” says Nguyen, pointing out that a lack of physical activity and poor eating habits could be contributing factors to negative heart health outcomes in some of these participants.

Ge urges people who get COVID-19 to talk to their healthcare providers and prioritize their heart health post-recovery. Steps to take include:

  • Pursuing heart-healthy diets, exercise, and smoking cessation
  • Taking steps to manage heart disease risk factors, including high blood pressure, diabetes, and LDL cholesterol
  • Considering statins or other anti-inflammatory agents under medical guidance
  • Getting regular heart screenings and imaging if they’re at high-risk for heart attack or stroke
  • Staying vigilant for symptoms of heart distress, including chest pain and shortness of breath

Source link

Exit mobile version